Table 2.

Intragroup and intergroup neurologic scoring results

Groups	Pre-op	Post-op1	Post-op7	Post-op14
	(Mean ± SD)	(Mean ± SD)	(Mean ± SD)	(Mean ± SD)
Control	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z
Sham	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z	0,00 ± 0,00 c, z
I/R	0,00 ± 0,00 c, z	2,00 ± 0,50 a, x	2,11 ± 0,33 a, x	2,55 ± 0,52 a, x
I/R + Vehicle	0,00 ± 0,00 c, z	2,33 ± 0,50 a, x	2,22 ± 0,44 a, x	2,44 ± 0,52 a, x
I/R + Naringin	0,00 ± 0,00 c, z	1,80 ± 0,78 a, y	1,60 ± 0,84 a, y	1,10 ± 0,31 b, y

*a,b,c shows the statistical difference in the same row (a > b > c) (P < 0.001); x,y,z shows the statistical difference in the same column (x > y > z) (P < 0.001). I/R led to increasing neurologic score levels, however, naringin supplementation improved neurologic score levels especially on days 7th and 14th after BCCAo/r